1 00:00:19,690 --> 00:00:21,339 >> Christine Gordon: Welcome back to Part Two of Four. 2 00:00:22,230 --> 00:00:24,600 In this section, we will discuss the following. 3 00:00:24,600 --> 00:00:25,830 Overview of the data cycle 4 00:00:25,830 --> 00:00:28,300 and how clinical research data is handled, 5 00:00:28,300 --> 00:00:30,190 the purpose of source documentation, 6 00:00:30,190 --> 00:00:32,730 what case report forms are, and data standards. 7 00:00:34,620 --> 00:00:36,090 So how is data handled? 8 00:00:36,090 --> 00:00:37,840 At a quick glance, data management 9 00:00:37,840 --> 00:00:40,060 actually begins with adequate and accurate source 10 00:00:40,060 --> 00:00:42,570 documents from which the data can be abstracted 11 00:00:42,570 --> 00:00:45,760 or even electronically extracted onto a case report form. 12 00:00:46,450 --> 00:00:48,900 After data quality checks by the research team, 13 00:00:48,900 --> 00:00:51,570 a database, and a sponsor, if applicable, 14 00:00:51,570 --> 00:00:53,320 the data can be cleaned and verified 15 00:00:53,320 --> 00:00:56,420 for transfer to a data analysis software or to the sponsor. 16 00:00:58,330 --> 00:00:59,860 So where does the data come from? 17 00:00:59,860 --> 00:01:02,110 Well, let's start with what source documents are 18 00:01:02,110 --> 00:01:03,320 and their purpose. 19 00:01:03,320 --> 00:01:05,380 Source documents are the original source 20 00:01:05,380 --> 00:01:06,980 that documents the raw data. 21 00:01:07,620 --> 00:01:11,210 These sources document the existence of the subject, 22 00:01:11,210 --> 00:01:12,430 they substantiate compliance 23 00:01:12,430 --> 00:01:15,390 with the protocol and integrity of the study data, 24 00:01:15,390 --> 00:01:16,810 and they serve as an audit trail, 25 00:01:16,810 --> 00:01:19,710 which allows one to recreate the progression of the trial. 26 00:01:21,020 --> 00:01:24,310 Source documents may be found in the subject's medical record, 27 00:01:24,310 --> 00:01:25,910 hospital record or clinic chart. 28 00:01:26,550 --> 00:01:29,640 Some examples include physical exam findings, 29 00:01:29,640 --> 00:01:31,750 documentation of the consent process, 30 00:01:31,750 --> 00:01:34,090 diagnostic reports, operative reports, 31 00:01:34,090 --> 00:01:36,580 laboratory reports, data reported, 32 00:01:36,580 --> 00:01:39,160 or data recorded from automated instruments. 33 00:01:39,160 --> 00:01:42,070 Some source data, such as quality of life surveys 34 00:01:42,070 --> 00:01:43,990 and other patient recorded outcomes 35 00:01:43,990 --> 00:01:47,730 or PK worksheets may not be found in the medical record, 36 00:01:47,730 --> 00:01:50,730 but rather in a research record; however, at a minimum, 37 00:01:50,730 --> 00:01:52,850 there should be some notation in the medical record 38 00:01:52,850 --> 00:01:55,530 that surveys were collected or when PKs were drawn. 39 00:01:57,970 --> 00:01:59,520 Clinical research source documentation 40 00:01:59,520 --> 00:02:00,750 in the medical record 41 00:02:00,750 --> 00:02:04,020 contains a bit more detail than in general clinical practice. 42 00:02:04,020 --> 00:02:05,840 For example in clinical research, 43 00:02:05,840 --> 00:02:08,630 we need to document the start dates of concomitant medications 44 00:02:08,630 --> 00:02:10,230 and their indication for use. 45 00:02:10,820 --> 00:02:12,780 Also, research source documentation 46 00:02:12,780 --> 00:02:15,460 is never by exception, meaning if normal, 47 00:02:15,460 --> 00:02:18,210 there is no documentation. In clinical research 48 00:02:18,210 --> 00:02:20,460 there must be documentation that something is normal 49 00:02:20,460 --> 00:02:22,510 in order to capture accurate data. 50 00:02:25,860 --> 00:02:28,490 Per good clinical practice, a case report form, 51 00:02:28,490 --> 00:02:31,690 also known as the CRF, is a printed or electronic form 52 00:02:31,690 --> 00:02:33,390 used in the trial to record information 53 00:02:33,390 --> 00:02:34,650 about the participant 54 00:02:34,650 --> 00:02:36,449 as identified by the study protocol. 55 00:02:37,450 --> 00:02:40,460 CRFs allow us to record data in a manner 56 00:02:40,460 --> 00:02:42,500 that is both efficient and accurate, 57 00:02:42,500 --> 00:02:45,060 record data in a manner that is suitable for processing, 58 00:02:45,060 --> 00:02:46,660 analysis and reporting. 59 00:02:49,950 --> 00:02:52,470 Electronic or paper case report form creation 60 00:02:52,470 --> 00:02:54,360 is a critical step in data management 61 00:02:54,360 --> 00:02:56,210 because if the correct data is not collected, 62 00:02:56,210 --> 00:02:57,859 it will impact the trial results. 63 00:02:58,450 --> 00:03:00,680 Case report form should be created based on the protocol 64 00:03:00,680 --> 00:03:01,920 and whenever possible, 65 00:03:01,920 --> 00:03:05,130 the raw data versus the derived data should be collected. 66 00:03:05,130 --> 00:03:07,290 For example collecting the date of birth 67 00:03:07,290 --> 00:03:09,650 rather than the age will provide more information 68 00:03:09,650 --> 00:03:12,810 because the age can be derived using other dates. 69 00:03:13,360 --> 00:03:15,260 This will help facilitate exchange of data 70 00:03:15,260 --> 00:03:17,580 across projects and organizations. 71 00:03:17,580 --> 00:03:19,670 All CRFs should be accompanied by completion 72 00:03:19,670 --> 00:03:21,270 or an instruction manual. 73 00:03:24,000 --> 00:03:27,330 General considerations for CRF development include 74 00:03:27,330 --> 00:03:29,340 collect data outlined in the protocol, 75 00:03:29,340 --> 00:03:32,180 collect data required by regulatory agencies, 76 00:03:32,180 --> 00:03:34,220 collect data with all users in mind, 77 00:03:34,220 --> 00:03:38,520 be clear and concise with data questions, avoid duplication, 78 00:03:38,520 --> 00:03:41,090 request minimal free text responses, 79 00:03:41,090 --> 00:03:43,750 collect data that allows for efficient computerization, 80 00:03:43,750 --> 00:03:45,900 and develop version control procedures. 81 00:03:48,210 --> 00:03:51,650 The consequences of poorly designed forms include the data 82 00:03:51,650 --> 00:03:53,670 actually needed for analysis of primary 83 00:03:53,670 --> 00:03:56,250 and secondary endpoints is not collected, 84 00:03:56,250 --> 00:03:59,190 the data collected at not part of the study protocol, 85 00:03:59,190 --> 00:04:01,460 data collected that can easily be analyzed, 86 00:04:02,030 --> 00:04:04,650 requesting the same information more than once, 87 00:04:04,650 --> 00:04:08,360 eCRF screens that don't display all data in a single display, 88 00:04:08,360 --> 00:04:10,610 for example, a scrollbar must be used 89 00:04:10,610 --> 00:04:12,690 which may result in missing data, 90 00:04:12,690 --> 00:04:15,480 and not using form or data standards. 91 00:04:15,480 --> 00:04:17,780 Poorly designed CRFs will likely cost more in the long run 92 00:04:17,780 --> 00:04:19,000 due to corrections 93 00:04:19,000 --> 00:04:21,700 and modifications needed throughout the study. 94 00:04:24,500 --> 00:04:26,810 There are pros and cons to developing CRFs 95 00:04:26,810 --> 00:04:29,820 during protocol development and after protocol finalization. 96 00:04:30,870 --> 00:04:33,900 Ideally though, CRF developments should begin as soon as possible 97 00:04:33,900 --> 00:04:35,650 in the protocol development process 98 00:04:36,190 --> 00:04:38,340 and should use the protocol visit schedule. 99 00:04:39,150 --> 00:04:40,460 During a protocol development, 100 00:04:40,460 --> 00:04:42,900 a pro may include identification of problems 101 00:04:42,900 --> 00:04:45,800 with protocol procedures prior to protocol finalization. 102 00:04:46,330 --> 00:04:48,790 A con may include numerous versions of CRFs 103 00:04:48,790 --> 00:04:52,460 may be necessary. After protocol finalization, 104 00:04:52,460 --> 00:04:55,370 a pro includes fewer versions of CRFs 105 00:04:55,370 --> 00:04:57,890 and fewer reviews prior to finalization. 106 00:04:58,540 --> 00:05:02,020 A con includes if issues between CRF and data 107 00:05:02,020 --> 00:05:03,270 and protocol rights, 108 00:05:03,270 --> 00:05:05,210 a protocol amendment may be required. 109 00:05:06,390 --> 00:05:07,880 No matter when CRFs are developed, 110 00:05:07,880 --> 00:05:10,400 all appropriate individuals need to be part of the process 111 00:05:10,400 --> 00:05:12,670 or at least have an interdisciplinary review 112 00:05:12,670 --> 00:05:14,780 such as the statistician, the investigator, 113 00:05:14,780 --> 00:05:18,090 the site coordinator database designer or programmer, 114 00:05:18,090 --> 00:05:19,690 clinical monitor and data management 115 00:05:19,690 --> 00:05:21,290 and data entry personnel. 116 00:05:23,470 --> 00:05:26,130 Even though data collection forms are based on the protocol, 117 00:05:26,130 --> 00:05:28,670 they usually contain certain categories or data modules, 118 00:05:28,670 --> 00:05:30,120 along with key identifiers 119 00:05:30,120 --> 00:05:32,070 such as the site identification number, 120 00:05:32,590 --> 00:05:35,250 protocol number, and unique patient identifier. 121 00:05:35,250 --> 00:05:37,410 These modules include the header, 122 00:05:37,410 --> 00:05:39,990 which usually includes key identifying information, 123 00:05:39,990 --> 00:05:43,540 study number, center number, subject identification number. 124 00:05:44,370 --> 00:05:47,440 Safety modules may include demographic information, 125 00:05:47,440 --> 00:05:51,460 inclusion or exclusion criteria, adverse events, medical history, 126 00:05:51,460 --> 00:05:53,940 or cancer history, physical exams, 127 00:05:53,940 --> 00:05:56,950 including vital signs, concomitant medications, 128 00:05:56,950 --> 00:06:00,370 laboratory tests, procedures drug accountability, 129 00:06:00,370 --> 00:06:02,070 deaths in off study reasons. 130 00:06:02,990 --> 00:06:06,030 Efficacy modules are typically unique modules 131 00:06:06,030 --> 00:06:07,790 and they can be more difficult to develop. 132 00:06:07,790 --> 00:06:10,690 The protocol would dictate which elements should be included, 133 00:06:10,690 --> 00:06:13,250 and this could be a repeated battery of tests. 134 00:06:13,250 --> 00:06:16,370 The module should define key efficacy endpoints in the trial, 135 00:06:17,230 --> 00:06:19,600 mainly the primary/secondary endpoints, 136 00:06:19,600 --> 00:06:22,360 additional tests to measure efficacy, 137 00:06:22,360 --> 00:06:25,260 such as quality of life and required diagnostics, 138 00:06:25,260 --> 00:06:27,159 and may include baseline measurements. 139 00:06:29,460 --> 00:06:31,400 Standards are a document established 140 00:06:31,400 --> 00:06:33,650 by consensus that provides rules, guidelines, 141 00:06:33,650 --> 00:06:36,810 and characteristics for specific activities or results. 142 00:06:36,810 --> 00:06:38,120 There are a number of organizations 143 00:06:38,120 --> 00:06:40,180 developing standards and involved in standards 144 00:06:40,180 --> 00:06:43,470 development initiatives. When developing CRFs, 145 00:06:43,470 --> 00:06:45,350 using standards for both the data questions 146 00:06:45,350 --> 00:06:48,660 and answers allows for rapid data exchange, 147 00:06:48,660 --> 00:06:51,470 removes the need for data mapping during data exchange, 148 00:06:51,470 --> 00:06:53,810 allows for consistent reporting across protocols 149 00:06:53,810 --> 00:06:55,300 for across projects, 150 00:06:55,300 --> 00:06:59,390 promotes monitoring and investigator staff efficiency, 151 00:06:59,390 --> 00:07:01,900 allows the merging of data between studies, 152 00:07:01,900 --> 00:07:04,070 provides increased efficiency and processing 153 00:07:04,070 --> 00:07:05,720 an analysis of the clinical data. 154 00:07:08,030 --> 00:07:09,390 Some of the more well-known 155 00:07:09,390 --> 00:07:11,160 standards development organizations 156 00:07:11,160 --> 00:07:13,820 are ISO, the International Organization 157 00:07:13,820 --> 00:07:18,040 for Standardization, HL7, Health Level 7, 158 00:07:18,040 --> 00:07:22,170 CEN, European Committee for Standardization and CDISC, 159 00:07:23,060 --> 00:07:25,640 Clinical Data Integration Standards Consortium. 160 00:07:26,280 --> 00:07:28,970 These organizations design standards for data structure 161 00:07:28,970 --> 00:07:31,160 or modeling exchange and data semantics. 162 00:07:31,920 --> 00:07:33,200 There are several types of standards 163 00:07:33,200 --> 00:07:36,230 using clinical research, including data exchange. 164 00:07:36,230 --> 00:07:39,580 This facilitates the ability for the sender to communicate 165 00:07:39,580 --> 00:07:42,600 with the receiver of information on format and type of data. 166 00:07:43,270 --> 00:07:46,310 Data format identifies the data and outlines 167 00:07:46,310 --> 00:07:48,400 the location of the data in a dataset. 168 00:07:49,170 --> 00:07:50,770 Semantic data elements, 169 00:07:50,770 --> 00:07:53,010 which standardize the data element name, 170 00:07:53,010 --> 00:07:55,640 defines the data element, and lists permissible values 171 00:07:55,640 --> 00:07:57,630 or possible responses to question. 172 00:07:58,990 --> 00:08:02,750 CDISC is an open, global, multidisciplinary, 173 00:08:02,750 --> 00:08:05,400 nonprofit organization that has established standards 174 00:08:05,930 --> 00:08:09,720 to support the acquisition, exchange, and submission 175 00:08:09,720 --> 00:08:12,770 archive of clinical research, data and metadata. 176 00:08:12,770 --> 00:08:15,700 CDISC standards are vendor neutral, platform independent 177 00:08:15,700 --> 00:08:18,100 and freely available via the CDISC website. 178 00:08:18,950 --> 00:08:22,070 Clinical Data Acquisition Standards Harmonization, 179 00:08:22,070 --> 00:08:23,580 also known as CDASH, 180 00:08:23,580 --> 00:08:25,160 is a standard for form development 181 00:08:25,160 --> 00:08:27,450 that is now widely used in clinical research. 182 00:08:28,360 --> 00:08:31,170 This will not only help developing quality forms, 183 00:08:31,170 --> 00:08:33,340 but may enable researchers to aggregate data 184 00:08:33,340 --> 00:08:35,710 from other studies using the standard. 185 00:08:35,710 --> 00:08:37,890 The standard describes the basic recommended data 186 00:08:37,890 --> 00:08:40,000 collection fields for 16 domains, 187 00:08:40,000 --> 00:08:42,060 including demographics, adverse events, 188 00:08:42,060 --> 00:08:44,890 and other domains that are common to most therapeutic areas 189 00:08:44,890 --> 00:08:46,520 and phases of clinical research. 190 00:08:49,480 --> 00:08:51,960 In this session, we learned that data management 191 00:08:51,960 --> 00:08:55,350 actually begins with adequate and accurate source documents. 192 00:08:55,350 --> 00:08:58,180 The purpose of source documents is to document the existence 193 00:08:58,180 --> 00:09:01,460 of the subject, substantiate compliance with the protocol 194 00:09:01,460 --> 00:09:03,160 and the integrity of the study data, 195 00:09:03,160 --> 00:09:04,910 and also serves as the audit trail. 196 00:09:05,590 --> 00:09:08,830 We also discussed that CRFs are printed or electronic forms 197 00:09:08,830 --> 00:09:11,350 used in the trial to record information about 198 00:09:11,350 --> 00:09:14,440 the participant as identified by the study protocol. 199 00:09:14,440 --> 00:09:16,540 The use of CRFs allows to record data 200 00:09:16,540 --> 00:09:18,950 in a manner that is both efficient and accurate, 201 00:09:18,950 --> 00:09:21,350 record data in a manner that is suitable for processing, 202 00:09:21,350 --> 00:09:22,950 analysis and reporting. 203 00:09:23,790 --> 00:09:26,310 Ideally, CRF development begins as soon as possible 204 00:09:26,310 --> 00:09:28,120 in the protocol development process 205 00:09:28,120 --> 00:09:30,270 and should use the protocol visit schedule. 206 00:09:31,030 --> 00:09:33,350 We covered that standards are a document established 207 00:09:33,350 --> 00:09:35,560 by consensus that provide rules, guidelines, 208 00:09:35,560 --> 00:09:38,560 or characteristics for specific activities or results 209 00:09:39,070 --> 00:09:40,270 and when developing CRFs 210 00:09:40,270 --> 00:09:42,150 using standards for both the data questions 211 00:09:42,150 --> 00:09:45,120 and answers allows for rapid exchange of data, 212 00:09:45,120 --> 00:09:47,740 removes the need for mapping through deep exchanges, 213 00:09:47,740 --> 00:09:51,070 allows for consistent reporting across protocols and projects, 214 00:09:51,070 --> 00:09:54,370 promotes monitoring and investigator staff efficiency, 215 00:09:54,370 --> 00:09:56,720 and allows the merging of data between studies, 216 00:09:56,720 --> 00:09:58,970 as well as provides increased efficiency and data 217 00:09:58,970 --> 00:10:01,030 processing in analysis of the data. 218 00:10:03,770 --> 00:10:05,740 Let's see if you can answer these questions. 219 00:10:05,740 --> 00:10:07,940 What is the purpose of source documentation? 220 00:10:08,690 --> 00:10:10,440 And what does the case report form? 221 00:10:13,060 --> 00:10:14,660 Thank you for your time.